AXSM stock forecast
Our latest prediction for Axsome Therapeutics, Inc.'s stock price was made on the June 29, 2020 when the stock price was at 76.36$.
In the short term (2weeks), AXSM's stock price should underperform the market by -1.65%. During that period the price should oscillate between -10.67% and +10.11%.
In the medium term (3months), AXSM's stock price should underperform the market by -5.09%. During that period the price should oscillate between -40.54% and +24.82%.Get email alerts
Create a solid portfolio with AXSM
About Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14 which are developing for multiple pain and primary care indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.57$ per share.
The book value per share is 0.27$
Three months stock forecastJune 29, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|